Home Adagene's ADG138 NDA Accepted by China's NMPA — Stock Volatility Signals Renewed Market Interest

Adagene's ADG138 NDA Accepted by China's NMPA — Stock Volatility Signals Renewed Market Interest

May 30, 2026 05:59 CST Updated 07:15
Adagene

Developer of Novel Cancer Immunotherapies